You are here
Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider
Sunnyvale, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a new allergy testing services agreement with a major healthcare company specializing in patient health and wellness. Arrayit offers simple non-invasive testing services that measure reactivity of immunoglobulin E (IgE) antibodies to an extensive panel of food, environmental and specialty allergens as a precision healthcare solution to assist physicians in the diagnosis and treatment of allergy and asthma. The healthcare leader provides health and pharmacy services to more than 10 million retail, commercial and corporate customers and reports revenues exceeding $35,000,000,000 ($35 billion dollars) annually.
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, signed allergy testing contracts with a consortium of 178 medical clinics, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS), reported the sale and shipping of clinical instrumentation to the FDA, launched the Patient Data Solutions allergy portal for doctors and clinics, and celebrated 25 years of company operations. Adding a major new payor in the health and wellness sector expands Arrayit’s allergy testing footprint among healthcare recipients in both the government and commercial health insurance markets.
Chief Executive Officer Rene Schena states, “We are pleased to announce a new allergy testing services agreement with a major healthcare provider. The provider’s focus on lifelong well-being through the deployment of transformative healthcare solutions aligns perfectly with our miniaturized, multiplexed and highly automated allergy testing services that deliver personalized medical information consistent with preventative health and wellness models.”
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the research, biotechnology, pharmaceutical, clinical and healthcare sectors through the discovery, development and manufacture of proprietary life science and personalized medicine products and services to advance biomedical research and improve wellness and human health. Please visit www.arrayit.com for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's public filings.
CONTACT: CONTACT Public Relations Arrayit Corporation Tel: 408-744-1331 Email: firstname.lastname@example.org Web: www.arrayit.com